Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Authors
Keywords
-
Journal
BRAIN
Volume 139, Issue 9, Pages 2540-2553
Publisher
Oxford University Press (OUP)
Online
2016-07-12
DOI
10.1093/brain/aww160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- (2016) Maria Bjerke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET
- (2016) Danielle van Westen et al. Scientific Reports
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
- (2015) Michael Ewers et al. Alzheimers & Dementia
- What does it mean to be ‘amyloid-positive’?
- (2015) Anne M. Fagan BRAIN
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
- (2015) Tiia Ngandu et al. LANCET
- Use of amyloid-PET to determine cutpoints for CSF markers
- (2015) Marissa D. Zwan et al. NEUROLOGY
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Comparison of qualitative and quantitative imaging characteristics of [ 11 C]PiB and [ 18 F]flutemetamol in normal control and Alzheimer's subjects
- (2015) James M. Mountz et al. NeuroImage-Clinical
- mixtools: AnRPackage for Analyzing Finite Mixture Models
- (2015) Tatiana Benaglia et al. Journal of Statistical Software
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- Pathways to Alzheimer's disease
- (2014) J. Hardy et al. JOURNAL OF INTERNAL MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Analytical aspects of molecular Alzheimer’s disease biomarkers
- (2012) Ulf Andreasson et al. Biomarkers in Medicine
- A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
- (2012) Agneta Nordberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
- (2012) M. Scholl et al. NEUROLOGY
- Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
- (2011) Stephen D. Weigand et al. Alzheimers & Dementia
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
- (2011) G. D. Rabinovici et al. NEUROLOGY
- High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
- (2010) A. Forsberg et al. Current Alzheimer Research
- Pittsburgh Compound-B and Alzheimer’s Disease Biomarkers in CSF, Plasma and Urine: An Exploratory Study
- (2010) M. Degerman Gunnarsson et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A screening UHPLC–MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species
- (2010) Lieve Dillen et al. Bioanalysis
- Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly
- (2009) Anne M. Fagan et al. ANNALS OF NEUROLOGY
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
- (2009) Nigel J. Cairns et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding
- (2009) N. Tolboom et al. JOURNAL OF NUCLEAR MEDICINE
- Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements
- (2009) R. L. McNamee et al. JOURNAL OF NUCLEAR MEDICINE
- Relationships between biomarkers in aging and dementia
- (2009) W. J. Jagust et al. NEUROLOGY
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
- (2008) J. Koivunen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now